Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Conditions

GliomaGlioblastoma MultiformeAnaplastic Astrocytoma

Interventions

DRUG

LS11 (talaporfin sodium)

DEVICE

Light source (interstitial light emitting diodes)

PROCEDURE

Intraoperative placement of device in glioma

Trial Locations (1)

Institute of Neurosurgery, Clinical Centre Serbia, Belgrade